The study added to a large existing volume of evidence that has consistently shown a risk-reducing effect of OBS on ovarian cancer, said Karen H. Lu, MD, of Moffitt Cancer Center in Tampa, Florida and ...

Ice dancer Piper Gilles has more to celebrate than just making the 2026 Canadian Figure Skating Team at the 2026 Olympic ...

Early menarche, late menopause, and long reproductive span increase ovarian cancer risk, particularly in postmenopausal women ...

Ainsley Cole, a Dunedin High School graduate and University of South Florida psychology student, is battling an exceptionally ...

World Cancer Day shines a spotlight on progress in cancer prevention and treatment, and doctors, such as those in the ...

Ovarian cancer is characterized by uncontrolled growth of cells in the ovaries. It can progress to another part of the body ...

Ovarian cancer standard of care has not advanced in over 30 years, but a new DNA-based immunotherapy could be a gamechanger, showing major survival gains in clinical trials.

A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.

A prevention strategy developed by Canadian researchers can reduce the risk of the most common and deadly form of ovarian ...

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...

Gemogenovatucel-T is a DNA-engineered, triple-function immunotherapy that utilizes a patient's autologous tumor cells as a source for the complete matrix of tumor-related clonal signals. Its mechanism ...

The discovery that tumor vasculature has a molecular profile distinct from normal resting vessels identified tumor vasculature as an important new clinical target. Two recent large studies profiling ...